The George Institute
2 clinical trials · 2 recruiting · OTHER
Trials by The George Institute
RECRUITINGNCT05788042
Trial of Enhanced Neurostimulation for Anorexia
Preliminary open-label studies have suggested that non-invasive brain stimulation methods of both transcranial direct current stimulation (tDCS) and repetitive transcranial...
Sponsor: The George InstituteEnrolling: 701 location
Anorexia Nervosa
RECRUITINGPhase 3NCT05345327
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
The aim of the trial is to evaluate the effects of the SGLT2 inhibitor, dapagliflozin, compared to metformin on annual decline in eGFR when used as first line therapy in people...
Sponsor: The George InstituteEnrolling: 9948 locations
Type 2 Diabetes